Sun Yat-sen University Cancer Center

This study is testing if adding the antibiotic moxifloxacin to standard first-line chemotherapy helps people with metastatic triple-negative breast cancer live longer without their cancer getting worse. It will involve about 228 participants across multiple centers. Patients will…

This study is testing if adding a drug called bevacizumab to a precise form of radiation therapy works better for people with lung cancer that has spread to the brain. It will compare the combination to radiation alone and to a different type of whole-brain radiation. The main go…